Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

March concessionary prices announced

The Department of Health and National Assembly for Wales have agreed concessionary prices for the following items for March 2017 prescriptions.

Drug
Strength
Form
Price
Amitriptyline
50mg
tablets (28)
£3.50
Dapsone
50mg
tablets (28)
£46.19
Exemestane
25mg
tablets (30)
£12.60
Flecainide
50mg
tablets (60)
£11.57
Flecainide
100mg
tablets (60)
£16.53
Glibenclamide
5mg
tablets (28)
£2.49
Lorazepam
1mg
tablets (28)
£6.00
Mirtazapine
15mg
tablets (28)
£5.95
Mirtazapine
30mg
tablets (28)
£1.61
Mirtazapine
45mg
tablets (28)
£5.95
Naratriptan
2.5mg
tablets (6)
£23.00
Nitrofurantoin
50mg
tablets (28)
£20.50
Oxazepam
10mg
tablets (28)
£7.97
Oxazepam
15mg
tablets (28)
£7.75
Ropinirole
1mg
tablets (84)
£56.71
Ropinirole
5mg
tablets (84)
£165.00
Spironolactone
50mg
tablets (28)
£5.20
Valsartan
40mg
capsules (28)
£8.95
Valsartan
80mg
capsules (28)
£11.99
Valsartan
160mg
capsules (28)
£17.65
Zolmitriptan
2.5mg
sugar-free orodispersible tablets (6)
£15.22
Zolmitriptan
2.5mg
tablets (6)
£15.30

What do you make of these new prices?

Related Content

Topics



Pharmacist Managers - Recruiting Now !
East London, Essex and Luton
£40,000 - £50,000 per year

Apply Now
UsernamePublicRestriction

Register

CD008646

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel